The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Join Foundation President and CEO, Michael Boyle, MD, and other Foundation staff as they highlight the latest CF research and developments in our drug pipeline, discuss how our care model is evolving to meet changing needs, and provide an update on the Foundation’s Path to a Cure, our ambitious research initiative focused on developing treatments for the underlying cause of the disease for all people with CF and, ultimately, a cure.